<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Variations in blood concentrations of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (<z:chebi fb="21" ids="53713">APA</z:chebi>) were investigated through the course of pregnancy in women who had a history of recurrent pregnancy loss, and were related to changes in pregnancy outcome </plain></SENT>
<SENT sid="1" pm="."><plain>Serial measurements of <z:chebi fb="21" ids="53713">APA</z:chebi> were made in 16 women with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) and 16 with negative <z:chebi fb="21" ids="53713">APA</z:chebi> tests pre-pregnancy </plain></SENT>
<SENT sid="2" pm="."><plain>There was considerable intraindividual variation in test results through pregnancy </plain></SENT>
<SENT sid="3" pm="."><plain>There was a significantly higher ratio of dilute Russell's viper venom time and IgG ACA titre in the first trimester compared with results pre-pregnancy in women with APS </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, transiently positive <z:chebi fb="21" ids="53713">APA</z:chebi> results were noted in the control group during pregnancy and some women with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> tested negative for <z:chebi fb="21" ids="53713">APA</z:chebi> in mid- and <z:e sem="disease" ids="C0878751" disease_type="Disease or Syndrome" abbrv="">late pregnancy</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>We have demonstrated clinically important variations in the results of tests for <z:chebi fb="21" ids="53713">APA</z:chebi> during pregnancy in women with APS </plain></SENT>
</text></document>